Sabra Health Care REIT
(NASDAQ) SBRA
Sabra Health Care REIT Financials at a Glance
Market Cap
$4.95B
Revenue (TTM)
$774.63M
Net Income (TTM)
$155.61M
EPS (TTM)
$0.64
P/E Ratio
30.67
Dividend
$1.20
Beta (Volatility)
0.52 (Low)
Dividend
$1.20
Beta (Volatility)
0.52 (Low)
Price
$19.64
Volume
47,736
Open
$19.64
Price
$19.64
Volume
47,736
Open
$19.64
Previous Close
$19.64
Daily Range
$19.59 - $19.81
52-Week Range
$15.75 - $21.07
Dividend
$1.20
Beta (Volatility)
0.52 (Low)
Price
$19.64
Volume
47,736
Open
$19.64
Previous Close
$19.64
Daily Range
$19.59 - $19.81
52-Week Range
$15.75 - $21.07
SBRA News
SBRA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sabra Health Care REIT
Industry
Health Care REITs
Sector
Real EstateEmployees
58
CEO
Rick Matros
Website
www.sabrahealth.comHeadquarters
Irvine, CA 92612, US
SBRA Financials
Key Financial Metrics (TTM)
Gross Margin
65%
Operating Margin
34%
Net Income Margin
20%
Return on Equity
6%
Return on Capital
6%
Return on Assets
3%
Earnings Yield
3.26%
Dividend Yield
0.06%
Payout Ratio
1.86%
Stock Overview
Market Cap
$4.95B
Shares Outstanding
252.15M
Volume
47.74K
Short Interest
0.00%
Avg. Volume
2.74M
Financials (TTM)
Gross Profit
$503.53M
Operating Income
$263.87M
EBITDA
$456.83M
Operating Cash Flow
$348.61M
Capital Expenditure
$0.00
Free Cash Flow
$348.61M
Cash & ST Invst.
$71.54M
Total Debt
$2.55B
Sabra Health Care REIT Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$211.90M
+16.2%
Gross Profit
$131.49M
+7.3%
Gross Margin
62.05%
N/A
Market Cap
$4.95B
N/A
Market Cap/Employee
$98.99M
N/A
Employees
50
N/A
Net Income
$27.23M
-41.7%
EBITDA
$107.98M
-13.7%
Quarterly Fundamentals
Net Cash
$2.48B
-4.0%
Accounts Receivable
$111.29M
-15.5%
Inventory
$0.00
N/A
Long Term Debt
$2.57B
+9.9%
Short Term Debt
$217.58M
+104.2%
Return on Assets
2.83%
N/A
Return on Invested Capital
6.22%
N/A
Free Cash Flow
$87.43M
+9.3%
Operating Cash Flow
$87.43M
+9.3%